Skip to content

Vir Biotechnology, Inc. VIR Prepaid & Other Current

Prepaid & Other Current at other companies

Amgen logo
AmgenAMGN
$4.11B+26.2%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$620.9M+32.4%
Gilead Sciences logo
Gilead SciencesGILD
$4.34B+53.5%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$22.56M+9.5%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$12.93M-18.7%
Enliven Therapeutics logo
Enliven TherapeuticsELVN
$10.74M+125%

Other financials

Income statement

See full
Revenue-$29.0K-101%
Gross profit$1.2M-60.2%
Operating income-$132.3M+5.2%
Net income-$125.7M-3.9%
EPS (diluted)-$0.85+3.4%

Balance sheet

See full
Cash & equivalents$283.0M-23.1%
Total debt$95.6M-0.5%
Total equity$812.8M-22.1%
Total assets$1.0B-21.6%

Cash flow

See full
Operating cash flow-$132.4M-69.5%
CapEx$390.0K-76.1%
Free cash flow-$132.8M-66.5%

Valuation

See full
Market cap$1.71B+61.1%
Enterprise value$1.53B+102%
P/S26.2×-24.8×

Profitability

See full
Gross margin96.1%-2.7pp
Operating margin-720.8%-313pp
Net margin-676%-291pp
FCF margin-686.5%-273pp

Returns & leverage

See full
Return on equity-47.7%+3.6pp
Debt / equity0.1×0.0×
Current ratio7.1×+0.3×

Where this comes from

Reported directly by Vir Biotechnology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vir Biotechnology, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vir Biotechnology, Inc.'s prepaid & other current?
Vir Biotechnology, Inc. (VIR) reported prepaid & other current of $44.76M in Q1 2026.
How has Vir Biotechnology, Inc.'s prepaid & other current changed year-over-year?
Vir Biotechnology, Inc.'s prepaid & other current increased by 5.6% year-over-year, from $42.39M to $44.76M.
What is the long-term trend for Vir Biotechnology, Inc.'s prepaid & other current?
Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s prepaid & other current has grown at a 1.5% compound annual growth rate (CAGR), from $156.49M to $165.96M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.